Which has the lower trailing P/E, CVS or GSK?

GSK has the lower trailing P/E: CVS trades at 23.58 and GSK at 15.57. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CVS or GSK?

Over the past five years, CVS grew revenue faster — CVS at a 8.32% CAGR versus GSK at 1.38%.

Does CVS or GSK pay a bigger dividend?

CVS yields 2.81% and GSK yields 3.78% based on trailing dividends and the latest price.

Is CVS or GSK more profitable?

GSK runs the higher net margin — CVS at 1.18% versus GSK at 14.52%.

How have CVS and GSK total returns compared?

Over the past 10 years, CVS delivered 3.48% and GSK delivered 6.11% annualized total return. Past performance doesn't predict future results.

CVS Health Corp. (CVS) vs GSK plc (GSK)

A side-by-side comparison of CVS Health Corp. and GSK plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

CVS

CVS Health Corp.

$113.72B

$89.13HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

GSK

GSK plc

$98.65B

$49.24HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

Total return — CVS vs GSK

growth of $100 · dividends reinvested · last 10y

CVS +43.1% (+3.7%/yr)GSK +78.6% (+6.0%/yr)GSK compounded faster over this window

CVS GSK

CVS vs GSK: by the numbers

•CVS is the larger company ($113.72B vs $98.65B market cap).
•GSK trades at the lower trailing earnings multiple (15.57 vs 23.58 P/E), one valuation lens rather than an overall verdict.
•GSK converts more revenue to profit (14.52% vs 1.18% net margin).
•CVS grew revenue faster over the past five years (8.32% vs 1.38% CAGR).
•GSK pays the higher dividend yield (3.78% vs 2.81%).

Metrics side by side

Valuation

Metric	CVS	GSK
P/E ratio	23.58	15.57
Forward P/E	11.14	N/A
P/S ratio	0.27	2.23
P/B ratio	1.43	4.24
EV / EBITDA	13.95	7.97
FCF yield	10.34%	9.46%

Profitability

Metric	CVS	GSK
Gross margin	14.15%	72.71%
Operating margin	2.00%	20.72%
Net margin	1.18%	14.52%
ROE	6.16%	27.67%
ROIC	4.14%	13.95%

Dividends

Metric	CVS	GSK
Dividend yield	2.81%	3.78%
Payout ratio	70.37%	57.45%

Growth (annualized)

Metric	CVS	GSK
Revenue CAGR (5Y)	8.32%	1.38%
EPS CAGR (5Y)	-23.89%	-0.71%
FCF CAGR (5Y)	-10.28%	-2.45%
Total return CAGR (5Y)	5.91%	8.21%

Frequently asked

Which has the lower trailing P/E, CVS or GSK?: GSK has the lower trailing P/E: CVS trades at 23.58 and GSK at 15.57. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CVS or GSK?: Over the past five years, CVS grew revenue faster — CVS at a 8.32% CAGR versus GSK at 1.38%.
Does CVS or GSK pay a bigger dividend?: CVS yields 2.81% and GSK yields 3.78% based on trailing dividends and the latest price.
Is CVS or GSK more profitable?: GSK runs the higher net margin — CVS at 1.18% versus GSK at 14.52%.
How have CVS and GSK total returns compared?: Over the past 10 years, CVS delivered 3.48% and GSK delivered 6.11% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CVS analysis Full GSK analysis Interactive comparison tool

Dig into the metrics

CVS Health P/E ratio GSK P/E ratio CVS Health dividend yield GSK dividend yield CVS Health ROE GSK ROE CVS Health operating margin GSK operating margin CVS Health revenue growth GSK revenue growth CVS Health free cash flow GSK free cash flow

CVS Health & GSK appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.